General https://www.benzinga.com/views/taxonomy/term/18467 en Vans Shoes Co-Founder Paul Van Doren Dies At 90 https://www.benzinga.com/news/21/05/21024235/vans-shoes-co-founder-paul-van-doren-dies-at-90 <p>Paul Van Doren, the co-founder of the Vans shoe brand, has died at age 90.</p> <p><strong>What Happened</strong>: Vans&nbsp;announced Van Doren&#39;s death on&nbsp;<a href="https://twitter.com/VANS_66/status/1390729426913087490" target="_blank">Twitter</a>&nbsp;on Friday.&nbsp;</p> <p>&quot;We send our love and strength to the Van Doren family and the countless Vans Family members who have brought Paul&#39;s legacy to life,&quot; the company said.</p> <p><strong>California Roots</strong>:&nbsp;The Van Doren Rubber Company was <a href="https://www.nbcnews.com/news/obituaries/paul-van-doren-co-founder-vans-shoes-dead-90-n1266734">established in early 1966</a>. Van Doren, his brother James and business ...</p><p><a href=https://www.benzinga.com/news/21/05/21024235/vans-shoes-co-founder-paul-van-doren-dies-at-90 alt=Vans Shoes Co-Founder Paul Van Doren Dies At 90>Full story available on Benzinga.com</a></p> Dickies JanSport News Paul Van Doren supreme The North Face Timberland Vans Shoes Entrepreneurship Success Stories General News Entrepreneurship Success Stories General Benzinga Sat, 08 May 2021 18:02:23 +0000 Bibhu Pattnaik 21024235 at https://www.benzinga.com Wells Fargo Championship Live Odds, How To Watch In US For May 8 https://www.benzinga.com/trading-ideas/long-ideas/21/05/21023942/wells-fargo-championship-live-odds-how-to-watch-in-us-for-may-8 <p>The third round of the <strong>Wells Fargo &amp; Co</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wfc#NYSE">WFC</a>) Championship is live and underway at Quail Hollow Golf Course in Charlotte, North Carolina. How can you watch Saturday&rsquo;s action and who&rsquo;s favored going into Day 3?</p> <h3>Watch Wells Fargo Championship 2021</h3> <p>Television coverage begins at 1 p.m. EST Saturday and continues ...</p><p><a href=https://www.benzinga.com/trading-ideas/long-ideas/21/05/21023942/wells-fargo-championship-live-odds-how-to-watch-in-us-for-may-8 alt=Wells Fargo Championship Live Odds, How To Watch In US For May 8>Full story available on Benzinga.com</a></p> DKNG Golf Long Ideas MGM PGA sports betting Wells Fargo Championship WFC Sports Trading Ideas General MGM US5529531015 WFC US9497461015 DKNG Long Ideas Sports Trading Ideas General Benzinga Sat, 08 May 2021 17:06:01 +0000 Henry Khederian 21023942 at https://www.benzinga.com If Sports Content Is King, Sinclair's DTC Model Could Be A Home Run https://www.benzinga.com/general/sports/21/05/21016991/if-sports-content-is-king-sinclairs-dtc-model-could-be-a-home-run <p><strong>Sinclair Broadcast Group Inc</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbgi#NASDAQ">SBGI</a>) acquired the regional sports channels from the <strong>Walt Disney Co</strong>&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dis#NYSE">DIS</a>) in 2019.</p> <p>Since then, Sinclair&nbsp;has&nbsp;struggled to gain traction with streaming and monetizing the regional sports networks, even&nbsp;taking a writedown on the acquisition.&nbsp;A new plan to monetize the sports content could be coming and is one that investors should watch.</p> <p><strong>What Happened:</strong> On its first-quarter earnings call, Sinclair&nbsp;announced plans to launch its regional sports networks in a direct-to-consumer (DTC)&nbsp;platform with several pricing plans.</p> <p>The company recently rebranded the channels from the Fox Sports name to Bally Sports through a naming partnership with <strong>Bally&#39;s Corp</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/baly#NYSE">BALY</a>). The local channels carry rights to MLB, NBA and NHL teams.&nbsp;</p> <p>The teams <a href="https://www.tvtechnology.com/news/sinclair-to-launch-bally-sports-dtc-platform-in-2022">are</a>:</p> <p>Bally Sports West/Bally Sports Socal: Los Angeles Angels, Los Angeles Kings, Anaheim Ducks, Los Angeles Clippers</p> <p>Bally Sports Arizona: Arizona Coyotes, Arizona Diamondbacks, Phoenix Suns</p> <p>Bally Sports Southwest: ...</p><p><a href=https://www.benzinga.com/general/sports/21/05/21016991/if-sports-content-is-king-sinclairs-dtc-model-could-be-a-home-run alt=If Sports Content Is King, Sinclair&#039;s DTC Model Could Be A Home Run>Full story available on Benzinga.com</a></p> BALY DIS DISH GOOG GOOGL Hulu MLB NBA NHL SBGI Sling TV Sports Stocks YouTube TV Sports Trading Ideas General DISH US25470M1099 GOOG US38259P7069 SBGI US8292261091 DIS US2546871060 GOOGL US38259P5089 BALY Sports Trading Ideas General Benzinga Sat, 08 May 2021 15:00:41 +0000 Chris Katje 21016991 at https://www.benzinga.com EssayUSA Has Made Admissions Easy With its 24/7 Writing Service https://www.benzinga.com/pressreleases/21/05/g21023354/essayusa-has-made-admissions-easy-with-its-247-writing-service <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>Los Angeles, CA, May 08, 2021 (GLOBE NEWSWIRE) -- From college admission essays to subject-specific essays, EssayUSA offers writing services in a number for a number of purposes. As the schools have gone online, the testing methods have also changed to adapt to the limitations of at-home online exams.</p> <p>This change can be observed in the admission tests conducted by the universities. Not everyone has a perfect bandwidth internet and a working camera and microphone to take the online admission tests according to the new rules. For this very reason, universities have chosen to not conduct entrance tests. SAT and ACT scores are not being necessitated by colleges. Admission tests have been made optional by more than 900 colleges by the beginning of 2021. This trend is expected to carry itself to 2022 too. But taking out tests doesn&#39;t mean that colleges are now open to take without a criterion. That&#39;s where other bars ...</p><p><a href=https://www.benzinga.com/pressreleases/21/05/g21023354/essayusa-has-made-admissions-easy-with-its-247-writing-service alt=EssayUSA Has Made Admissions Easy With its 24/7 Writing Service>Full story available on Benzinga.com</a></p> Press Releases General Sat, 08 May 2021 09:23:12 +0000 Globe Newswire 21023354 at https://www.benzinga.com The Woman's Hospital of Texas and Designer Kendra Scott Team Up to Celebrate National Nurses Week https://www.benzinga.com/pressreleases/21/05/g21022623/the-womans-hospital-of-texas-and-designer-kendra-scott-team-up-to-celebrate-national-nurses-week <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>Houston, Texas, May 07, 2021 (GLOBE NEWSWIRE) -- Hundreds of nurses at The Woman&#39;s Hospital of Texas were surprised with a special event this morning in honor of National Nurses Week.<br /><br />World-renowned jewelry and home accessories designer Kendra Scott teamed up with The Woman&#039;s Hospital of Texas for a "surprise and delight" event for the hospital&#039;s nurses to inspire and lift the spirits of these incredible healthcare workers. Scott and her team chose The Woman&#039;s Hospital of Texas, whose nursing staff is over 98% female, to recognize the tireless work they continue to do to safeguard moms and babies and provide compassionate care since the start of the COVID-19 pandemic. <br /><br />The event began with welcome messages from The Woman&#039;s Hospital of Texas&#039; chief executive officer, Elizabeth Ortega, and chief nursing officer, Ann Russell.<br /><br />A video message from Kendra Scott herself was shown to the crowd of nurses thanking them for their heroic work over the past year. &#34;This week as we take a moment to show gratitude for our nurses and healthcare workers, I am reminded of the tireless bravery and heroism they&#39;ve shown throughout this past year," said Scott, founder and executive chairwoman of Kendra Scott. "It is an honor ...</p><p><a href=https://www.benzinga.com/pressreleases/21/05/g21022623/the-womans-hospital-of-texas-and-designer-kendra-scott-team-up-to-celebrate-national-nurses-week alt=The Woman&#039;s Hospital of Texas and Designer Kendra Scott Team Up to Celebrate National Nurses Week>Full story available on Benzinga.com</a></p> lifestyle Health Care Press Releases General Sat, 08 May 2021 00:22:27 +0000 Globe Newswire 21022623 at https://www.benzinga.com COVID-19 Vaccine Patent Polarizes The World: What You Need To Know https://www.benzinga.com/general/biotech/21/05/21015721/covid-19-vaccine-patent-polarizes-the-world-what-you-need-to-know <p>The COVID-19 pandemic is continuing to rage unabated. Just as countries across the globe were coming online from a protracted lockdown, the second and third wave of the pandemic is threatening to derail hopes of a return to a more normal way of life.&nbsp;</p> <p>It&#39;s against this backdrop that vaccines and treatments options have taken center stage.</p> <p><strong>The COVID-19 Vaccine Landscape: </strong>In the U.S., three vaccines have received authorization for emergency use. <strong>Pfizer Inc. </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pfe#NYSE">PFE</a>)-<strong>BioNTech SE </strong>(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bntx#NASDAQ">BNTX</a>) were the first to get the <a href="https://www.benzinga.com/general/biotech/20/12/18762366/pfizer-biontech-gets-fda-nod-for-emergency-use-of-coronavirus-vaccine-deliveries-to-begin-immedia?utm_source=dlvr.it&amp;utm_medium=facebook"> nod </a> for emergency use, followed by <strong>Moderna, Inc. </strong>(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrna#NASDAQ">MRNA</a>) and <strong>Johnson &amp; Johnson </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jnj#NYSE">JNJ</a>).</p> <p><strong>AstraZeneca PLC&#39;s </strong>(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/azn#NASDAQ">AZN</a>) adenovirus vaccine &mdash; AZD1222 &mdash;&nbsp;has been approved for emergency use in several countries, although the FDA has&nbsp;yet to give its blessings.</p> <p>Some of the other vaccines approved internationally include Russia&#39;s Sputnik V, India&#39;s indigenously developed COVAXIN and a trio of vaccines developed by Chinese companies.</p> <p>The coronavirus vaccines have not received full approval. Pfizer and its German partner BioNTech announced Friday the initiation of a rolling submission for af biologic license application for full FDA approval of the companies&#39;&nbsp;mRNA vaccine, BNT162b2.</p> <p>The aim of governments is to make these vaccines as widely available as possible, especially to developing and underdeveloped countries, and vaccinate as many people as possible so that herd immunity may be achieved.</p> <p>One aspect that could come in the way of this objective are patents related to the vaccines.</p> <p><strong>How Patents Influence Vaccine Availability: </strong> A patent, in layman&#39;s terms, is the protection vested on an innovation that will allow the developer or the inventor to take ...</p><p><a href=https://www.benzinga.com/general/biotech/21/05/21015721/covid-19-vaccine-patent-polarizes-the-world-what-you-need-to-know alt=COVID-19 Vaccine Patent Polarizes The World: What You Need To Know>Full story available on Benzinga.com</a></p> AZN Biotech BNTX Coronavirus Covid-19 IBB JNJ MRNA News NVAX PFE vaccine Health Care Top Stories General IBB US4642875565 NVAX US6700021040 AZN US0463531089 JNJ US4781601046 PFE US7170811035 MRNA US56804Q1022 BNTX News Biotech Health Care Top Stories General Benzinga Fri, 07 May 2021 20:24:39 +0000 Shanthi Rexaline 21015721 at https://www.benzinga.com Science 37 Taps SPAC For NASDAQ Listing Valued At Around $1B https://www.benzinga.com/news/21/05/21017327/science-37-taps-spac-for-nasdaq-listing-valued-at-around-1b <ul> <li><strong>Science 37</strong>, a life science company, is tapping the craze of a special purpose acquisition company to help it with a major public listing.</li> <li>Specifically, its is&nbsp;<a class="editor-rtfLink" href="https://www.businesswire.com/news/home/20210507005149/en/Science-37-to-Become-Publicly-Listed-via-Merger-with-LifeSci-Acquisition-II-Corp.-Powering-the-Clinical-Trial-Operating-System-of-the-Future" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">penning a merger agreement</a>&nbsp;with&nbsp;<strong>LifeSci Acquisition II Corp</strong>&nbsp;(NASDAQ:&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/stock/lsaq#NASDAQ" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">LSAQ</a>).</li> <li>According to its statement, the offering sees Science 37 valued at just over $1 billion and has ...</li></ul><p><a href=https://www.benzinga.com/news/21/05/21017327/science-37-taps-spac-for-nasdaq-listing-valued-at-around-1b alt=Science 37 Taps SPAC For NASDAQ Listing Valued At Around $1B>Full story available on Benzinga.com</a></p> Briefs LSAQ News SPACs SPACs Attack Health Care Financing IPOs General LSAQ News Health Care Financing IPOs General Benzinga Fri, 07 May 2021 20:00:28 +0000 Vandana Singh 21017327 at https://www.benzinga.com EMA Safety Committee Reviews Heart Inflammation, Rare Nerve Disorder Reports After Pfizer, AstraZeneca COVID-19 Shots https://www.benzinga.com/general/biotech/21/05/21016760/ema-safety-committee-reviews-heart-inflammation-rare-nerve-disorder-reports-after-pfizer-astrazen <p>European Medical Agency (EMA) is&nbsp;<a class="editor-rtfLink" href="https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-3-6-may-2021" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">reviewing reports</a>&nbsp;of a rare nerve-degenerating disorder in people who received&nbsp;<strong>AstraZeneca Plc&rsquo;s</strong>&nbsp;(NASDAQ:&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/stock/azn#NASDAQ" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">AZN</a>) COVID-19 vaccine, raising new questions about potential side effects of the shot.</p> <p><strong>What Happened:</strong>&nbsp;As part of a regular review of safety reports for the vaccine, the safety committee of EMA is analyzing data provided by AstraZeneca on cases of Guillain-Barre syndrome (GBS). However, it did not specify the number of cases.</p> <p>The regulator said GBS was identified as a possible adverse event that needed to be specifically monitored during the vaccine&rsquo;s conditional approval process, adding it had requested more detailed data on the cases from AstraZeneca.</p> <p>However, researchers have ...</p><p><a href=https://www.benzinga.com/general/biotech/21/05/21016760/ema-safety-committee-reviews-heart-inflammation-rare-nerve-disorder-reports-after-pfizer-astrazen alt=EMA Safety Committee Reviews Heart Inflammation, Rare Nerve Disorder Reports After Pfizer, AstraZeneca COVID-19 Shots>Full story available on Benzinga.com</a></p> AZN Biotech BNTX COVID-19 Vaccine European Medicines Agency (EMA) Government JNJ MRNA News PFE Health Care FDA General AZN US0463531089 JNJ US4781601046 PFE US7170811035 MRNA US56804Q1022 BNTX News Biotech Government Health Care FDA General Benzinga Fri, 07 May 2021 19:56:10 +0000 Vandana Singh 21016760 at https://www.benzinga.com Galapagos Drops Early Metabolic & Osteoarthritis Programs, Reorganizes R&D Efforts https://www.benzinga.com/general/biotech/21/05/21016432/galapagos-drops-early-metabolic-osteoarthritis-programs-reorganizes-r-d-efforts <ul> <li><strong>Galapagos NV</strong>&nbsp;(NASDAQ:&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/stock/glpg#NASDAQ" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">GLPG</a>)<a class="editor-rtfLink" href="https://www.globenewswire.com/news-release/2021/05/06/2224971/0/en/Galapagos-refocuses-pipeline-and-rightsizes-operations.html" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">&nbsp;is chopping its pipeline to</a>&nbsp;conserve cash while its business development team pursues a mission to find a &ldquo;transformative&rdquo; deal for the company.</li> <li>The company is ditching its Idiopathic pulmonary fibrosis (IPF) molecule &rsquo;1205 while moving ahead with a Phase 2 IPF study for its chitinase inhibitor &rsquo;4617.</li> <li>It is also dropping early research efforts in metabolic diseases and osteoarthritis while cutting back on non-core areas of R&amp;D focus. This decision will cost ...</li></ul><p><a href=https://www.benzinga.com/general/biotech/21/05/21016432/galapagos-drops-early-metabolic-osteoarthritis-programs-reorganizes-r-d-efforts alt=Galapagos Drops Early Metabolic &amp; Osteoarthritis Programs, Reorganizes R&amp;D Efforts>Full story available on Benzinga.com</a></p> Biotech Briefs Earnings GLPG GLPGF News osteoarthritis Health Care General GLPGF GLPG News Earnings Biotech Health Care General Benzinga Fri, 07 May 2021 19:49:37 +0000 Vandana Singh 21016432 at https://www.benzinga.com McKesson Shares Move Higher After Strong FY22 Guidance, Goldman Sachs Price Target Hike https://www.benzinga.com/news/earnings/21/05/21015933/mckesson-shares-move-higher-after-strong-fy22-guidance-goldman-sachs-price-target-hike <ul> <li><strong>McKesson Corporation</strong>&nbsp;(NYSE:&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/stock/mck#NYSE" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">MCK</a>)&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/pressreleases/21/05/b20999855/mckesson-reports-fiscal-2021-fourth-quarter-and-full-year-results" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">reported fourth-quarter FY21 EPS of $5.05</a>, which beat the analyst consensus estimate of $5.04 versus $4.27 a year ago.</li> <li>Sales increased 1% Y/Y to $59.14 billion, which missed the analyst consensus estimate of $61.09 billion.</li> <li>Revenue growth of 1% Y/Y was primarily due to market growth and higher volumes from retail national account customers in the U.S. Pharmaceutical segment.</li> <li>U.S. Pharmaceutical Segment revenues were $47.0 billion, an increase of 3% Y/Y, driven by market growth and higher volumes from retail national account customers, partially offset by ...</li></ul><p><a href=https://www.benzinga.com/news/earnings/21/05/21015933/mckesson-shares-move-higher-after-strong-fy22-guidance-goldman-sachs-price-target-hike alt=McKesson Shares Move Higher After Strong FY22 Guidance, Goldman Sachs Price Target Hike>Full story available on Benzinga.com</a></p> Briefs Earnings MCK News Guidance Health Care General MCK US58155Q1031 News Earnings Guidance Health Care General Benzinga Fri, 07 May 2021 19:46:04 +0000 Vandana Singh 21015933 at https://www.benzinga.com New Music NFT BAND Royalty Presale Sells Nearly $1M in NFTs https://www.benzinga.com/pressreleases/21/05/g21018489/new-music-nft-band-royalty-presale-sells-nearly-1m-in-nfts <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>SINGAPORE, May 07, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- <a href="https://www.globenewswire.com/Tracker?data=rRbtqCLJnyYSFxAYtW83-5Q613WL02mwHmyez1rSAT-KhO2XYDQ5BzSNhNFwoiKMsdVihhGhxUXK8W9p-KqfSg==" rel="nofollow" target="_blank" rel="nofollow"><u>BAND Royalty</u></a> ("BAND" or the "Company"), operated by Singapore-based LIBERTY IS PTE LTD, has just concluded the private presale round of its NFT music art BAND NFT Series 1 collectibles to a small selection of NFT collectors that love music. Within days of this announcement, the top three Diamond Album BAND NFTs sold for a combined 60 ETH (currently valued at over $200,000 USD).</p> <p>Included in the top three Diamond Album NFTs was the No. 1 minted Double Diamond Album BAND NFT, which sold for 25 ETH (currently valued at over $85,000 USD). As is typically the case with highly sought-after, limited-edition collectible NFTs, the lower the mint number, the higher the perceived market value of that specific NFT minted.</p> <p>In this limited-edition collectible set of BAND Royalty NFTs, collectors were keen to jump into the presale and secure the lowest mint numbered NFTs possible for a few key reasons: They were not only impressed by the stunning 3D animated artwork on each NFT, combined with the unique numbering on each BAND NFT, but they were fascinated by how BAND Royalty innovated this set of NFTs beyond anything else in the current NFT marketplace.</p> <p>The fact that BAND Royalty developed an innovative method to share music royalty streaming revenues with a community of BAND NFT holders was a world first, for both the nascent crypto NFT industry and a potentially worldwide game-changing landmark event for the music industry itself.</p> <p>For all these reasons, the combined private presale of BAND NFTs approached $1 million USD in less than two weeks of its announcement, which was made to the fortunate community of a couple of hundred in-the-know NFT collectors who wanted to get in and ...</p><p><a href=https://www.benzinga.com/pressreleases/21/05/g21018489/new-music-nft-band-royalty-presale-sells-nearly-1m-in-nfts alt=New Music NFT BAND Royalty Presale Sells Nearly $1M in NFTs>Full story available on Benzinga.com</a></p> Arts & Entertainment News Press Releases General Fri, 07 May 2021 19:34:35 +0000 Globe Newswire 21018489 at https://www.benzinga.com APYSwap Announces Solana Bridge to Further Cross-Chain Interoperability https://www.benzinga.com/news/21/05/21018058/apyswap-announces-solana-bridge-to-further-cross-chain-interoperability <p><a href="https://apyswap.com/">APYSwap</a>, a protocol for the decentralized exchange of shares of Tokenized Vaults, is announcing a bridge to the Solana Ecosystem. This bridge is aimed at expanding APYSwap&rsquo;s cross-chain interoperability to non-EVM blockchains in addition to solving certain challenges when bridging from Ethereum.</p> <p> From the start APYSwap bridge is supporting token exchange between Ethereum, Solana, Binance Smart Chain and Huobi ECO Chain. Although only APYS token can be swapped at the moment, it can be done from any to any blockchain in the supported list.</p> <p> APYSwap is not the first bridge to Solana, there is also a Wormhole bridge, which has launched recently. Wormhole is a great product, which for now supports token transfers between Ethereum and Solana ...</p><p><a href=https://www.benzinga.com/news/21/05/21018058/apyswap-announces-solana-bridge-to-further-cross-chain-interoperability alt=APYSwap Announces Solana Bridge to Further Cross-Chain Interoperability>Full story available on Benzinga.com</a></p> Blockchain LaunchTeam News Partner Content General News General Benzinga Fri, 07 May 2021 19:11:03 +0000 Jared Polites 21018058 at https://www.benzinga.com NFL's First Crypto Partnership: New York Giants And Grayscale Investments https://www.benzinga.com/markets/cryptocurrency/21/05/20982583/nfls-first-crypto-partnership-new-york-giants-and-grayscale-investments <p>The New York Giants joined forces with the largest digital asset manager in the space, Grayscale Investments marking NFL&rsquo;s first-ever cryptocurrency partnership.</p> <p><strong>What Happened: </strong>The Giants <a href="https://www.giants.com/news/grayscale-investments-first-cryptocurrency-partner-of-nfl-team" style="color:#0563c1; text-decoration:underline">announced</a> the exclusive partnership on Wednesday, calling Grayscale the team&rsquo;s &ldquo;Official Digital Currency Asset Management Partner&rdquo;.</p> <p>&quot;Our partnership with the Giants is incredibly meaningful because our roots are in New York,&quot; said Grayscale CEO, Michael Sonnenshein.</p> <p>In light of partnership, Grayscale will also be the Giant&rsquo;s home game sponsor, supporting sponsor of the ...</p><p><a href=https://www.benzinga.com/markets/cryptocurrency/21/05/20982583/nfls-first-crypto-partnership-new-york-giants-and-grayscale-investments alt=NFL&#039;s First Crypto Partnership: New York Giants And Grayscale Investments>Full story available on Benzinga.com</a></p> $BTC Cryptocurrency Fintech football New York Giants News NFTs Sports Management Markets General $BTC News Cryptocurrency Fintech Sports Management Markets General Benzinga Fri, 07 May 2021 19:10:15 +0000 Samyuktha Sriram 20982583 at https://www.benzinga.com Auris Medical Stock Is Trading Higher As Bentrio Hit Primary Endpoint Goal In Allergic Rhinitis Study https://www.benzinga.com/general/biotech/21/05/21014819/auris-medical-stock-is-trading-higher-as-bentrio-hit-primary-endpoint-goal-in-allergic-rhinitis-s <ul> <li><strong>Auris Medical Holding Ltd&nbsp;</strong>(NASDAQ:&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/stock/ears#NASDAQ" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">EARS</a>) has&nbsp;<a class="editor-rtfLink" href="https://www.globenewswire.com/news-release/2021/05/07/2225554/0/en/Auris-Medical-Provides-Update-on-Bentrio-Program-in-Allergy.html" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">announced additional information</a>&nbsp;regarding the results from the clinical trial of its nasal spray, Bentrio, meant for treating people suffering from allergic rhinitis.</li> <li>Additionally, the company also provided an essential update about the regulatory path for the product in the U.S.</li> <li>Bentrio managed to hit the primary endpoint about the clinical evaluation into allergic rhinitis.</li> <li>More importantly, the reduction in nasal symptoms was not only significant but also clinically relevant.</li> <li>On the other hand, ...</li></ul><p><a href=https://www.benzinga.com/general/biotech/21/05/21014819/auris-medical-stock-is-trading-higher-as-bentrio-hit-primary-endpoint-goal-in-allergic-rhinitis-s alt=Auris Medical Stock Is Trading Higher As Bentrio Hit Primary Endpoint Goal In Allergic Rhinitis Study>Full story available on Benzinga.com</a></p> Allergic Rhinitis Biotech Briefs EARS News Penny Stocks Health Care General EARS News Biotech Penny Stocks Health Care General Benzinga Fri, 07 May 2021 19:01:06 +0000 Vandana Singh 21014819 at https://www.benzinga.com Dickey's Barbecue Pit Expands Retail Line with New Pork Skins Online https://www.benzinga.com/pressreleases/21/05/g21017667/dickeys-barbecue-pit-expands-retail-line-with-new-pork-skins-online <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>Dallas, May 07, 2021 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=O5aFj_Ux7zdn1ZyS2hNNO0nr_mdwCuY7NJeR3MuE_jbQj2qrUnNuZINTMiShFCbpQkefLYRVIgNWJoQ0J6VPMBm335OCHMdemU88kSWnJgwCp1pMwEVhv6MwBXrDMlFk" rel="nofollow" target="_blank" rel="nofollow">Barbecue retailer and meal subscription service</a> Barbecue At Home by Dickey&#039;s is set to expand its retail line with unbelievably addicting pork skins snack in three flavors which includes an Original, Barbecue and Salt &amp; Vinegar flavors.</p> <p> </p> <p>The new crunchy pork skins are guaranteed to satisfy your snacking needs and will soon be available in over 3,000 stores and online through Dickey&#039;s Amazon storefront on amazon.com or athome.dickeys.com.</p> <p> </p> <p>"We&#039;re embracing our southern roots by rolling out a delicious light, airy and perfectly crunchy pork skin snack," said <a href="https://www.globenewswire.com/Tracker?data=_8dLo2OCXziyGphgh8zylIKZVrB6O-Rkc8T7LoFHCYmn8VsuWPuT9mbACxJakUuV6q0PwQUusaCFeq-i-HA7RoOgbzmPItTvCOf31SQqzwxIajTlXHyPDtA57DWE-9cXDeRLjPf88Q-csCx5eq07jZcv3LSQXUzOfxAPzsHUq4CSSahGtd78LQaxME7Yr7Ty" rel="nofollow" target="_blank" rel="nofollow">Laura Rea Dickey, CEO of Dickey&#039;s Barbecue Restaurants, Inc.</a> "Our focus is to share our Texas flavor with folks across the globe and we look forward to unveiling Dickey&#039;s  Barbecue Pit Original, Barbecue and Salt &amp; Vinegar Pork Skins."</p> <p> </p> <p>Dickey&#039;s plans to release ...</p><p><a href=https://www.benzinga.com/pressreleases/21/05/g21017667/dickeys-barbecue-pit-expands-retail-line-with-new-pork-skins-online alt=Dickey&#039;s Barbecue Pit Expands Retail Line with New Pork Skins Online>Full story available on Benzinga.com</a></p> Restaurants Press Releases General Fri, 07 May 2021 18:48:33 +0000 Globe Newswire 21017667 at https://www.benzinga.com